Table 3.

Patients’ status after transfusion and outcome after CP therapy.

Characteristic	Total n = 27	EN group n = 15	LN group n = 12	P value
Total volume dose of CP, median (IQR)—mL	400 (200–600)	400 (200–400)	400 (400–800)	0.861
Transfusion-related adverse reactions—no. (%)	0 (0)	0 (0)	0 (0)
Interval between first transfusion and discharge, median (IQR)—d	11.0 (6.0–25.0)	7.0 (4.0–11.0)	24.0 (14.7–28.7)
Pulmonary imaging improvement	15/20	7/8	8/12	0.603
Length of hospital stay, median (IQR)—d	43.0 (24.0–54.0)	37.0 (19.0–50.0)	52.0 (35.0–63.7)
Mortality of 60 days—no. (%)	3 (11.1)	0 (0)	3 (25)